enoximone has been researched along with verapamil in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Cheng, HC; Dage, RC; Grisar, JM; Hsieh, CP; Kariya, T; Roebel, LE; Schnettler, RA | 1 |
| Böhm, M; Hammer, B; Link, A; Weisgerber, K | 1 |
| Addario, C; Antonelli, M; Cavallaro, F; Ferro, G; Gallizzi, F; Sandroni, C | 1 |
8 other study(ies) available for enoximone and verapamil
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Pharmacology of enoximone.
Topics: Animals; Cardiotonic Agents; Cats; Dogs; Drug Interactions; Enoximone; Evaluation Studies as Topic; Guinea Pigs; Hemodynamics; Humans; Imidazoles; In Vitro Techniques; Myocardial Contraction; Myocardium; Oxygen Consumption; Papillary Muscles; Vasodilation; Verapamil | 1987 |
[Therapy of verapamil poisoning with noradrenaline and the phosphodiesterase inhibitor enoximone].
Topics: Adult; Calcium; Calcium Channel Blockers; Drug Therapy, Combination; Enoximone; Humans; Male; Norepinephrine; Phosphodiesterase Inhibitors; Poisoning; Shock, Cardiogenic; Sympathomimetics; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 2002 |
Successful treatment with enoximone for severe poisoning with atenolol and verapamil: a case report.
Topics: Adrenergic Agonists; Anti-Arrhythmia Agents; Atenolol; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dopamine; Drug Overdose; Enoximone; Epinephrine; Heart Rate; Humans; Male; Middle Aged; Severity of Illness Index; Time Factors; Treatment Outcome; Verapamil | 2004 |